Document ID: chunk:federal_register_of_legislation:F2021L01087:clause:1_1
Version: federal_register_of_legislation:F2021L01087
Segment Type: clause
Provision Reference: sch 1 cl 1
Character Range: 4350–6013

1         the number of submissions, being authorised prescriber applications, SAS A notifications and SAS B applications made in relation to relevant products, by reference to one or more of the following:
              (a)     a time period;
              (b)    the relevant pathway for the applications or notifications;
              (c)     the status of the applications or notifications, such as approved, withdrawn, refused, pending and received;
              (d)    the number of medical practitioners or health practitioners who made the applications or notifications;
              (e)     the states or territories in which the practitioners mentioned in paragraph (d) are located;
              (f)     the speciality (if any) of the practitioners mentioned in paragraph (d);
              (g)    the numbers of patients to whom authorised prescriber reports, SAS A notifications or SAS B applications relate by age range;
              (h)    the number of patients to whom authorised prescriber reports, SAS A notifications or SAS B applications relate by gender;
              (i)      the indications specified in the applications or notifications in relation to the relevant products;
              (j)      the dosage forms of the relevant products;
              (k)    the name and strength of the active ingredients of the relevant products;
              (l)      the schedule to the current Poisons Standard (otherwise known as the SUSMP Schedule) in which a substance contained in the relevant products is included;
              (m)  the number of patients for whom repeat approvals in relation to a SAS B application have been granted